Dawnrays Pharmaceutical Holdings Ltd. (HK:2348) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Dawnrays Pharmaceutical Holdings Ltd. has announced the grant of 16 million share options to 17 eligible employees, including the CEO, under their 2023 Share Option Scheme. The options are exercisable over six years with a staggered vesting schedule, starting at HK$1.25 per share. This incentive aims to motivate employees’ performance and commitment to the company’s success.
For further insights into HK:2348 stock, check out TipRanks’ Stock Analysis page.